S&P 500 7,734.14 ▲ 57.37 (+0.75%) DOW 52,438.94 ▲ 77.36 (+0.15%) NASDAQ 26,534.90 ▲ 365.51 (+1.40%) US Markets Open â€ĸ 03:35 PM ET

SLGL

Sol-Gel Technologies Ltd.

Price Chart
Latest Quote

$69.64

+0.02 (+0.02%)
Current Price
Previous Close $69.63
Open $72.00
Day High $72.00
Day Low $69.11
Volume 33,296
Fetched: 2026-10-27T19:35:55
Stock Information
Shares Outstanding 3.27M
Total Debt $770K
Cash Equivalents $47.93M
Revenue $1.79M
Net Income $-16.34M
Sector Healthcare
Industry Biotechnology
Market Cap $228.02M
EPS (TTM) $-5.61
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$180.81M
Sales$1.79M
Income$-16.34M
Book/sh$14.69
Cash/sh$14.64
Employees28
Financial Ratios
Quick Ratio9.87
Current Ratio10.37
Debt/Eq1.60
Returns & Margins
ROA-23.87%
ROE-40.85%
Operating Margin-704.23%
Ownership
Insider Ownership59.69%
Institutional Ownership43.02%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-8.67
P/S127.03
P/B4.74
Analyst Data
Recommendationstrong_buy
Target Price$152.50
Technical Indicators
SMA20$70.18
SMA50$69.69
SMA200$73.98
RSI44.19
ATR3.9009
Shares Float489K
Short Float13.78%
Short Ratio2.55
Volatility1.15
Rel Volume0.84
Performance History
Week+5.83%
Month+0.28%
Quarter-15.63%
6 Months-1.79%
YTD+65.23%
Year+78.58%
3 Years+358.19%
5 Years-25.43%
10 Years-48.94%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-10-27 $69.64 33,296
2026-10-26 $69.63 47,600
2026-10-23 $69.45 57,800
2026-10-22 $67.39 46,200
2026-10-21 $65.72 59,500
2026-10-20 $65.81 44,900
2026-10-19 $64.98 13,900
2026-10-16 $64.25 69,800
2026-10-15 $68.70 41,200
2026-10-14 $69.50 26,800
2026-10-13 $68.30 33,700
2026-10-12 $72.40 29,000
2026-10-09 $71.77 31,500
2026-10-08 $70.34 41,000
2026-10-07 $71.94 31,300
2026-10-06 $75.64 44,000
2026-10-05 $78.95 29,200
2026-10-02 $72.00 44,400
2026-10-01 $73.00 32,800
2026-09-30 $74.28 39,200
2026-09-29 $72.25 30,700
2026-09-28 $69.45 58,000
About Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.

📰 Latest News
No news articles available at the moment. Check back later for updates on SLGL.
Period:
Income Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Revenue
Total Revenue $19,388,000 $11,538,000 $1,554,000 $3,883,000
Operating Revenue $19,388,000 $11,538,000 $1,554,000 $3,883,000
Expenses
Total Expenses $26,926,000 $23,552,000 $30,859,000 $20,127,000
Net Non Operating Interest Income Expense $1,411,000 $1,434,000 $2,067,000 $1,321,000
Operating Expense $26,926,000 $23,552,000 $30,859,000 $20,127,000
Other Operating Expenses $-54,000 - $-55,000 -
General And Administrative Expense $4,176,000 $5,749,000 $7,373,000 $7,445,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-6,127,000 $-10,580,000 $-27,238,000 $-14,923,000
Net Interest Income $1,411,000 $1,434,000 $2,067,000 $1,321,000
Interest Income $1,411,000 $1,434,000 $2,067,000 $1,321,000
Normalized Income $-6,127,000 $-10,580,000 $-27,238,000 $-14,923,000
Net Income From Continuing And Discontinued Operation $-6,127,000 $-10,580,000 $-27,238,000 $-14,923,000
Total Operating Income As Reported $-7,538,000 $-12,014,000 $-29,305,000 $-16,244,000
Net Income Common Stockholders $-6,127,000 $-10,580,000 $-27,238,000 $-14,923,000
Net Income $-6,127,000 $-10,580,000 $-27,238,000 $-14,923,000
Net Income Including Noncontrolling Interests $-6,127,000 $-10,580,000 $-27,238,000 $-14,923,000
Net Income Continuous Operations $-6,127,000 $-10,580,000 $-27,238,000 $-14,923,000
Pretax Income $-6,127,000 $-10,580,000 $-27,238,000 $-14,923,000
Interest Income Non Operating $1,411,000 $1,434,000 $2,067,000 $1,321,000
Operating Income $-7,538,000 $-12,014,000 $-29,305,000 $-16,244,000
Per Share
Diluted EPS $-2.19 $-3.79 $-10.01 $-6.50
Basic EPS $-2.19 $-3.79 $-10.01 $-6.50
Other
Tax Effect Of Unusual Items $0 $0 $0 $0
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $-7,429,000 $-11,781,000 $-28,963,000 $-15,682,000
Reconciled Depreciation $109,000 $233,000 $342,000 $562,000
EBITDA (Bullshit earnings) $-7,429,000 $-11,781,000 $-28,963,000 $-15,682,000
EBIT $-7,538,000 $-12,014,000 $-29,305,000 $-16,244,000
Diluted Average Shares $2,785,875 $2,785,787 $2,708,708 $2,312,872
Basic Average Shares $2,785,875 $2,785,787 $2,708,708 $2,312,872
Diluted NI Availto Com Stockholders $-6,127,000 $-10,580,000 $-27,238,000 $-14,923,000
Research And Development $22,804,000 $17,803,000 $23,541,000 $12,682,000
Selling General And Administration $4,176,000 $5,749,000 $7,373,000 $7,445,000
Other Gand A $4,176,000 $5,749,000 $7,373,000 $7,445,000
Tax Provision - - - -
Fetched: 2026-10-23
Balance Sheet (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Assets
Net Tangible Assets $22,811,000 $28,850,000 $38,644,000 $42,213,000
Total Assets $29,917,000 $35,846,000 $45,287,000 $46,628,000
Total Non Current Assets $2,946,000 $4,551,000 $4,120,000 $3,573,000
Other Non Current Assets $1,386,000 $1,304,000 $1,339,000 $1,288,000
Current Assets $26,971,000 $31,295,000 $41,167,000 $43,055,000
Other Current Assets $1,004,000 $3,774,000 $2,794,000 $1,509,000
Receivables $1,968,000 $3,595,000 $377,000 $7,920,000
Accounts Receivable $1,968,000 $3,595,000 $377,000 $62,000
Cash Cash Equivalents And Short Term Investments $23,999,000 $23,926,000 $37,996,000 $33,626,000
Cash And Cash Equivalents $11,033,000 $19,489,000 $7,513,000 $12,448,000
Non Current Accounts Receivable - $1,024,000 - -
Other Receivables - - - $7,858,000
Prepaid Assets - - - -
Debt
Total Debt $991,000 $1,308,000 $1,653,000 $772,000
Long Term Debt And Capital Lease Obligation $496,000 $878,000 $1,206,000 $54,000
Current Debt And Capital Lease Obligation $495,000 $430,000 $447,000 $718,000
Liabilities
Total Liabilities Net Minority Interest $7,106,000 $6,996,000 $6,643,000 $4,415,000
Total Non Current Liabilities Net Minority Interest $935,000 $1,711,000 $2,121,000 $1,086,000
Current Liabilities $6,171,000 $5,285,000 $4,522,000 $3,329,000
Payables And Accrued Expenses $5,676,000 $4,855,000 $4,075,000 $2,611,000
Payables $2,765,000 $3,794,000 $2,021,000 $1,354,000
Other Payable $2,030,000 $2,529,000 $1,867,000 $1,103,000
Accounts Payable $735,000 $1,265,000 $154,000 $251,000
Equity
Common Stock Equity $22,811,000 $28,850,000 $38,644,000 $42,213,000
Total Equity Gross Minority Interest $22,811,000 $28,850,000 $38,644,000 $42,213,000
Stockholders Equity $22,811,000 $28,850,000 $38,644,000 $42,213,000
Retained Earnings $-237,010,000 $-230,883,000 $-220,303,000 $-193,065,000
Other
Ordinary Shares Number $2,786,158 $2,785,762 $2,785,762 $2,312,946
Share Issued $2,786,158 $2,785,762 $2,785,762 $2,312,946
Tangible Book Value $22,811,000 $28,850,000 $38,644,000 $42,213,000
Invested Capital $22,811,000 $28,850,000 $38,644,000 $42,213,000
Working Capital $20,800,000 $26,010,000 $36,645,000 $39,726,000
Capital Lease Obligations $991,000 $1,308,000 $1,653,000 $772,000
Total Capitalization $22,811,000 $28,850,000 $38,644,000 $42,213,000
Additional Paid In Capital $259,047,000 $258,959,000 $258,173,000 $234,640,000
Capital Stock $774,000 $774,000 $774,000 $638,000
Common Stock $774,000 $774,000 $774,000 $638,000
Employee Benefits $439,000 $833,000 $915,000 $1,032,000
Non Current Pension And Other Postretirement Benefit Plans $439,000 $833,000 $915,000 $1,032,000
Long Term Capital Lease Obligation $496,000 $878,000 $1,206,000 $54,000
Current Capital Lease Obligation $495,000 $430,000 $447,000 $718,000
Current Accrued Expenses $2,911,000 $1,061,000 $2,054,000 $1,257,000
Defined Pension Benefit $393,000 $595,000 $626,000 $749,000
Net PPE $1,167,000 $1,628,000 $2,155,000 $1,536,000
Accumulated Depreciation $-4,273,000 $-6,024,000 $-5,804,000 $-5,714,000
Gross PPE $5,440,000 $7,652,000 $7,959,000 $7,250,000
Leases $467,000 $1,982,000 $1,985,000 $1,993,000
Other Properties $4,225,000 $4,930,000 $5,235,000 $4,564,000
Machinery Furniture Equipment $748,000 $740,000 $739,000 $693,000
Properties $0 $0 $0 $0
Other Short Term Investments $12,966,000 $4,437,000 $30,483,000 $21,178,000
Fetched: 2026-10-23
Cash Flow Statement (Annual)
Metric 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Free Cash Flow
Free Cash Flow $275,000 $-13,891,000 $-17,864,000 $-9,655,000
Operating Activities
Operating Cash Flow $322,000 $-13,889,000 $-17,730,000 $-9,484,000
Cash Flow From Continuing Operating Activities $322,000 $-13,889,000 $-17,730,000 $-9,484,000
Operating Gains Losses $-246,000 $-55,000 $-49,000 $20,000
Investing Activities
Capital Expenditure $-47,000 $-2,000 $-134,000 $-171,000
Investing Cash Flow $-8,580,000 $26,692,000 $-9,742,000 $1,699,000
Cash Flow From Continuing Investing Activities $-8,580,000 $26,692,000 $-9,742,000 $1,699,000
Net Other Investing Changes - - - $10,000
Financing Activities
Issuance Of Capital Stock $0 $0 $21,542,000 $0
Financing Cash Flow $6,000 $0 $21,810,000 $15,000
Cash Flow From Continuing Financing Activities $6,000 $0 $21,810,000 $15,000
Net Common Stock Issuance $0 $0 $21,542,000 $0
Common Stock Issuance $0 $0 $21,542,000 $0
Other
End Cash Position $12,225,000 $20,665,000 $7,863,000 $13,598,000
Beginning Cash Position $20,665,000 $7,863,000 $13,598,000 $21,235,000
Effect Of Exchange Rate Changes $-188,000 $-1,000 $-73,000 $133,000
Changes In Cash $-8,252,000 $12,803,000 $-5,662,000 $-7,770,000
Proceeds From Stock Option Exercised $6,000 $0 $268,000 $15,000
Net Investment Purchase And Sale $-8,587,000 $26,688,000 $-9,682,000 $1,870,000
Sale Of Investment $5,523,000 $26,688,000 $14,295,000 $11,876,000
Purchase Of Investment $-14,110,000 $0 $-23,977,000 $-10,006,000
Net PPE Purchase And Sale $7,000 $4,000 $-60,000 $-171,000
Sale Of PPE $54,000 $6,000 $74,000 $0
Purchase Of PPE $-47,000 $-2,000 $-134,000 $-171,000
Change In Working Capital $6,192,000 $-4,402,000 $7,668,000 $3,538,000
Change In Payables And Accrued Expense $820,000 $780,000 $1,465,000 $-8,300,000
Change In Payable $820,000 $780,000 $1,465,000 $-8,300,000
Change In Account Payable $820,000 $780,000 $1,465,000 $-8,300,000
Change In Prepaid Assets $2,770,000 $-981,000 $-1,340,000 $-709,000
Change In Receivables $2,602,000 $-4,201,000 $7,543,000 $12,547,000
Changes In Account Receivables $1,626,000 $-3,218,000 $7,543,000 $12,547,000
Other Non Cash Items $286,000 $-46,000 $124,000 $-327,000
Stock Based Compensation $82,000 $786,000 $1,859,000 $1,527,000
Unrealized Gain Loss On Investment Securities $26,000 $175,000 $-436,000 $119,000
Depreciation Amortization Depletion $109,000 $233,000 $342,000 $562,000
Depreciation And Amortization $109,000 $233,000 $342,000 $562,000
Depreciation $109,000 $233,000 $342,000 $562,000
Pension And Employee Benefit Expense $-192,000 $-51,000 $6,000 $20,000
Gain Loss On Sale Of PPE $-54,000 $-4,000 $-55,000 $0
Net Income From Continuing Operations $-6,127,000 $-10,580,000 $-27,238,000 $-14,923,000
Income Tax Paid Supplemental Data - - $0 $0
Change In Other Working Capital - - - $-174,000
Fetched: 2026-10-23